On November 2, 2026, a blog post published by an MIT research team became a major topic among AI researchers. It claimed that ...

Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

Rising borrowing costs are taking a toll on households and businesses. But they are doing little to dampen enthusiasm for investments in A.I. infrastructure, which are contributing to inflation. By ...

Showing off this green tree python’s face becomes risky when the snake suddenly reacts. Its keeper jokes that the species is not famous for being sweet or relaxed, then learns that lesson firsthand ...

Compound interest is the mathematical process of an investment growing and building upon itself. The magic of compound returns for stocks is powerful because dividends get reinvested, making a small ...

The Federal Reserve raised interest rates for the first time since 2023 on Wednesday, reversing course as the Iran war drives up global energy prices and fuels inflation. The Fed raised the federal ...

The Federal Reserve just raised the cost of money — bad news for borrowers, good news for savers. The Fed increased its benchmark interest rate Wednesday by a quarter-point, the first rate hike since ...

The Federal Reserve on Wednesday raised its benchmark interest rate for the first time in over three years amid concerns over stubborn inflation that has been driven recently by higher energy prices.

At a nearly 90% likelihood as of Monday, the Federal Reserve is poised to issue its first interest rate hike since 2023 when it wraps its next meeting on September 16. According to the CME Group's ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.